Literature DB >> 11181113

Candidal vertebral osteomyelitis: report of 6 patients, and a review.

L Hendrickx1, E Van Wijngaerden, I Samson, W E Peetermans.   

Abstract

The incidence of deep-seated candidal infection is increasing, but candidal vertebral osteomyelitis is still rare. We describe 6 patients recently treated in our hospital. Conservative treatment failed in all. We reviewed the literature and identified 59 additional cases of candidal vertebral osteomyelitis. Candidemia was documented in 61.5% of them. The interval between the diagnosis of candidemia and the onset of symptoms of vertebral osteomyelitis varied widely, from days to >1 year. In patients without documented candidemia, there was a similar interval between the occurrence of risk factors for candidemia (present in 72% of the patients) and the onset of symptoms of vertebral osteomyelitis. Clinical, laboratory, and radiological findings are not specific for candidal spondylodiskitis. Final diagnosis is determined by means of culture of a biopsy specimen from the infected vertebra or disk. Treatment consisted of prolonged antifungal treatment, and it often included surgery. On the basis of our experience (for all 6 patients, initial conservative treatment with only antifungals failed), we recommend consideration of early surgical debridement in combination with prolonged antifungal therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11181113     DOI: 10.1086/318714

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Candida albicans osteomyelitis as a cause of chest pain and visual loss.

Authors:  Rita Magano; Joana Cortez; Evelise Ramos; Luís Trindade
Journal:  BMJ Case Rep       Date:  2015-10-16

2.  'Fungal spondylodiscitis in a non-immunocompromised patient'.

Authors:  Vanda Cristina Jorge; Catarina Cardoso; Carla Noronha; José Simões; Nuno Riso; Manuel Vaz Riscado
Journal:  BMJ Case Rep       Date:  2012-03-08

3.  Delayed presentation of Candidal Vertebral Osteomyelitis following penetrating spinal injury.

Authors:  S Dilip Chand Raja; Kanna Rishi Mugesh; Shetty Ajoy Prasad; S Rajasekaran
Journal:  J Clin Orthop Trauma       Date:  2019-02-23

Review 4.  Iliac bone Candida albicans osteomyelitis in a patient with iliac crest bone autograft: a case report and review of the literature.

Authors:  J R Yuste; M Alfonso; C Bustos; J Quintana; M Rubio; C Villas; J L Del Pozo
Journal:  Infection       Date:  2012-06-16       Impact factor: 3.553

Review 5.  Fungal spondylodiscitis in a patient recovered from H7N9 virus infection: a case study and a literature review of the differences between Candida and Aspergillus spondylodiscitis.

Authors:  Lie-Dao Yu; Zhi-Yun Feng; Xuan-Wei Wang; Zhi-Heng Ling; Xiang-Jin Lin
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

6.  [Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].

Authors:  C Voigt; H Lill
Journal:  Unfallchirurg       Date:  2006-11       Impact factor: 1.000

Review 7.  Management of destructive Candida albicans spondylodiscitis of the cervical spine: a systematic analysis of literature illustrated by an unusual case.

Authors:  Josef Stolberg-Stolberg; Dagmar Horn; Steffen Roßlenbroich; Oliver Riesenbeck; Stefanie Kampmeier; Michael Mohr; Michael J Raschke; René Hartensuer
Journal:  Eur Spine J       Date:  2016-11-05       Impact factor: 3.134

8.  Candida parapsilosis spondylodiscitis after lumbar discectomy.

Authors:  Kyungil Cho; Sun-Ho Lee; Eun-Sang Kim; Whan Eoh
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

9.  Cervical spondylodiscitis caused by Candida albicans in non-immunocompromised patient.

Authors:  Hyung Ho Moon; Jae Hoon Kim; Byung Gwan Moon; Joo Seung Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-01-20

10.  Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).

Authors:  Maria N Gamaletsou; Dimitrios P Kontoyiannis; Nikolaos V Sipsas; Brad Moriyama; Elizabeth Alexander; Emmanuel Roilides; Barry Brause; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.